MB, Levis & Associates’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

MB, Levis & Associates’s Portfolio IBDW Stock Details IBDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.8M	Buy	657,363 +6,869	+1%	+$145K	5.74%	5
2025 Q4	$13.8M	Buy	650,494 +10,086	+2%	+$214K	5.79%	5
2025 Q3	$13.6M	Buy	640,408 +1,681	+0.3%	+$35.4K	5.88%	6
2025 Q2	$13.4M	Buy	638,727 +10,028	+2%	+$207K	5.9%	6
2025 Q1	$13M	Buy	628,699 +3,518	+0.6%	+$72.2K	6.06%	6
2024 Q4	$12.7M	Buy	625,181 +9,580	+2%	+$198K	6.37%	5
2024 Q3	$13.1M	Buy	615,601 +10,076	+2%	+$210K	6.44%	5
2024 Q2	$12.3M	Buy	605,525 +16,530	+3%	+$334K	6.46%	5
2024 Q1	$12.1M	Buy	588,995 +12,825	+2%	+$262K	6.48%	5
2023 Q4	$12M	Buy	576,170 +33,847	+6%	+$667K	6.85%	5
2023 Q3	$10.5M	Buy	542,323 +9,455	+2%	+$188K	6.82%	7
2023 Q2	$10.8M	Buy	532,868 +84,175	+19%	+$1.72M	6.92%	6
2023 Q1	$9.26M	Buy	448,693 +42,498	+10%	+$867K	6.44%	6
2022 Q4	$8.08M	Buy	+406,195	New	+$8.04M	6.32%	7

Other funds holding IBDW

ACA

Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.22B AUM 22.28% 1-Year Est. Return

VVP

Venture Visionary Partners Sylvania, Ohio $3B AUM 24.41% 1-Year Est. Return

SVWA

Sarver Vrooman Wealth Advisors Kansas City, Missouri $168M AUM 7.75% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MB, Levis & Associates's IBDW Position: Q1 2026 in Review

MB, Levis & Associates increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 1.1% in Q1 2026, buying an estimated $145K and bringing the position to 657,363 shares worth $13.8M. The position accounts for 5.74% of the portfolio, ranked #5.

MB, Levis & Associates first reported a position in IBDW in Q4 2022 and has held it in 14 quarters since. 288 funds tracked by Wall St. Rank hold IBDW as of Q1 2026.

MB, Levis & Associates held 657,363 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $13.8M as of Q1 2026.
MB, Levis & Associates bought 6,869 iShares iBonds Dec 2031 Term Corporate ETF shares in Q1 2026, an estimated $145K.
iShares iBonds Dec 2031 Term Corporate ETF made up 5.74% of MB, Levis & Associates's portfolio in Q1 2026, its #5 holding.
MB, Levis & Associates first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q4 2022 and has held it in 14 quarters since.
288 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q1 2026.

Based on MB, Levis & Associates's 13F filing for Q1 2026, filed 8 Apr 2026.